Efficacy and tolerability of policosanol (25 mg/day) in patients with Type II Hyperlipoproteinemia

Documenti analoghi

• Comparison of the efficacy, safety and tolerability of policosanol and atorvastatin in patients with type II hypercholesterolemia
  di: Gladys Castaño
  Pubblicazione: (2005)
• Concomitant use of policosanol and cardiac glycosides in older patients
  di: Julio César Fernández-Travieso
  Pubblicazione: (2018)
• Effects of policosanol on patients with ischemic stroke with previous transient ischemic attack:a long-term follow-up
  di: Javier Sánchez
  Pubblicazione: (2010)
• Lipid profile and glycemic response of rats fed on a semi-purified diet supplemented with Agaricus brasiliensis mushroom
  di: Gilberto Simeone Henriques
  Pubblicazione: (2016)
• Concomitant use of policosanol and benzodiazepines in older patients
  di: Gladys Castaño
  Pubblicazione: (2007)